Regen BioPharma Inc - FORM 10-K - EX-32.2 - EXHIBIT 32.2 - January 4, 2018

Attached files

file filename
EX-10.2D - EXHIBIT 10.2D - Regen BioPharma Incex10_2d.htm
EX-10.1E - EXHIBIT 10.1E - Regen BioPharma Incex10_1e.htm
10-K - FORM 10-K - Regen BioPharma Incrgbp093017form10k.htm
EX-32.1 - EXHIBIT 32.1 - Regen BioPharma Incex32_1.htm
EX-31.2 - EXHIBIT 31.2 - Regen BioPharma Incex31_2.htm
EX-31.1 - EXHIBIT 31.1 - Regen BioPharma Incex31_1.htm
EX-10.21D - EXHIBIT 10.21D - Regen BioPharma Incex10_21d.htm
EX-10.20D - EXHIBIT 10.20D - Regen BioPharma Incex10_20d.htm
EX-10.19D - EXHIBIT 10.19D - Regen BioPharma Incex10_19d.htm
EX-10.18D - EXHIBIT 10.18D - Regen BioPharma Incex10_18d.htm
EX-10.17D - EXHIBIT 10.17D - Regen BioPharma Incex10_17d.htm
EX-10.16D - EXHIBIT 10.16D - Regen BioPharma Incex10_16d.htm
EX-10.15D - EXHIBIT 10.15D - Regen BioPharma Incex10_15d.htm
EX-10.14D - EXHIBIT 10.14D - Regen BioPharma Incex10_14d.htm
EX-10.13D - EXHIBIT 10.13D - Regen BioPharma Incex10_13d.htm
EX-10.12D - EXHIBIT 10.12D - Regen BioPharma Incex10_12d.htm
EX-10.11D - EXHIBIT 10.11D - Regen BioPharma Incex10_11d.htm
EX-10.10D - EXHIBIT 10.10D - Regen BioPharma Incex10_10d.htm
EX-10.9D - EXHIBIT 10.9D - Regen BioPharma Incex10_9d.htm
EX-10.8D - EXHIBIT 10.8D - Regen BioPharma Incex10_8d.htm
EX-10.7F - EXHIBIT 10.7F - Regen BioPharma Incex10_7f.htm
EX-10.7D - EXHIBIT 10.7D - Regen BioPharma Incex10_7d.htm
EX-10.6F - EXHIBIT 10.6F - Regen BioPharma Incex10_6f.htm
EX-10.6D - EXHIBIT 10.6D - Regen BioPharma Incex10_6d.htm
EX-10.5F - EXHIBIT 10.5F - Regen BioPharma Incex10_5f.htm
EX-10.5D - EXHIBIT 10.5D - Regen BioPharma Incex10_5d.htm
EX-10.4E - EXHIBIT 10.4E - Regen BioPharma Incex10_4e.htm
EX-10.4D - EXHIBIT 10.4D - Regen BioPharma Incex10_4d.htm
EX-10.3E - EXHIBIT 10.3E - Regen BioPharma Incex10_3e.htm
EX-10.3D - EXHIBIT 10.3D - Regen BioPharma Incex10_3d.htm
EX-10.2E - EXHIBIT 10.2E - Regen BioPharma Incex10_2e.htm
EX-10.1G - EXHIBIT 10.1G - Regen BioPharma Incex10_1g.htm
EX-10.1D - EXHIBIT 10.1D - Regen BioPharma Incex10_1d.htm
EX-10.1C - EXHIBIT 10.1C - Regen BioPharma Incex10_1c.htm

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report of Regen Biopharma, Inc. on Form 10-K for the year ended September 30, 2017 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Todd S. Caven, Chief Financial Officer certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. 

 

 Dated: 1/3/2018   By: /s/ Todd S. Caven
      Todd S. Caven
      Chief Executive Officer
       

 

 

Regen BioPharma Inc Reports